Answers are grounded in this paper and cite their sources.
A correlation has been identified between sex hormones and MS clinical activity. The combination of disease-modifying therapies with estrogen or estrogen plus a progestin receptor modulator promoting myelin repair might represent an important strategy for MS treatment in the future.
No takes yet. Share an insight, caveat, or question.
Murgia et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: